BackgroundUltra‐high field magnetic resonance imaging (MRI) has obvious advantages in acquiring high‐resolution images. 7 T MRI has been clinically approved and 21.1 T MRI has also been tested on rodents.PurposeTo examine the effects of ultra‐high field on mice behavior and neuron activity.Study TypeProspective, animal model.Animal ModelNinety‐eight healthy C57BL/6 mice and 18 depression model mice.Field Strength11.1–33.0 T SMF (static magnetic field) for 1 hour and 7 T for 8 hours. Gradients were not on and no imaging sequence was used.AssessmentOpen field test, elevated plus maze, three‐chambered social test, Morris water maze, tail suspension test, sucrose preference test, blood routine, biochemistry examinations, enzyme‐linked immunosorbent assay, immunofluorescent assay.Statistical TestsThe normality of the data was assessed by Shapiro–Wilk test, followed by Student's t test or the Mann–Whitney U test for statistical significance. The statistical cut‐off line is P < 0.05.ResultsCompared to the sham group, healthy C57/6 mice spent more time in the center area (35.12 ± 4.034, increased by 47.19%) in open field test and improved novel index (0.6201 ± 0.02522, increased by 16.76%) in three‐chambered social test a few weeks after 1 hour 11.1–33.0 T SMF exposure. 7 T SMF exposure for 8 hours alleviated the depression state of depression mice, including less immobile time in tail suspension test (58.32% reduction) and higher sucrose preference (increased by 8.80%). Brain tissue analysis shows that 11.1–33.0 T and 7 T SMFs can increase oxytocin by 164.65% and 36.03%, respectively. Moreover, the c‐Fos level in hippocampus region was increased by 14.79%.Data Conclusion11.1–33.0 T SMFs exposure for 1 hour or 7 T SMF exposure for 8 hours did not have detrimental effects on healthy or depressed mice. Instead, these ultra‐high field SMFs have anti‐depressive potentials.Evidence Level1Technical EfficacyStage 1